ロード中...
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
Hodgkin Lymphoma (HL) is a unique disease entity both in its pathology and the young patient population that it primarily affects. Although cure rates are high, survivorship can be linked with significant long-term morbidity associated with both chemotherapy and radiotherapy. The most significant re...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6025119/ https://ncbi.nlm.nih.gov/pubmed/29914088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10060204 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|